Balyasny Asset Management L.P. Trims Stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Balyasny Asset Management L.P. lessened its holdings in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 63.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 119,222 shares of the company's stock after selling 205,778 shares during the quarter. Balyasny Asset Management L.P. owned 0.19% of Guardian Pharmacy Services worth $2,415,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in GRDN. Envestnet Asset Management Inc. boosted its position in Guardian Pharmacy Services by 4.9% during the fourth quarter. Envestnet Asset Management Inc. now owns 12,010 shares of the company's stock worth $243,000 after purchasing an additional 564 shares during the period. LPL Financial LLC grew its stake in Guardian Pharmacy Services by 4.8% during the fourth quarter. LPL Financial LLC now owns 17,679 shares of the company's stock worth $358,000 after buying an additional 807 shares in the last quarter. R Squared Ltd acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at $30,000. Investment Research & Advisory Group Inc. acquired a new position in Guardian Pharmacy Services during the fourth quarter worth about $34,000. Finally, BNP Paribas Financial Markets acquired a new stake in Guardian Pharmacy Services in the fourth quarter valued at approximately $37,000.

Guardian Pharmacy Services Stock Performance

NYSE GRDN traded down $0.30 during trading hours on Friday, reaching $24.62. 88,787 shares of the company were exchanged, compared to its average volume of 146,109. The business's 50 day simple moving average is $22.63 and its 200-day simple moving average is $21.74. Guardian Pharmacy Services, Inc. has a 1 year low of $14.16 and a 1 year high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The firm had revenue of $329.31 million for the quarter, compared to analysts' expectations of $321.21 million. On average, research analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Analysts Set New Price Targets

Separately, Truist Financial increased their price target on Guardian Pharmacy Services from $24.00 to $25.00 and gave the company a "buy" rating in a research note on Friday, April 11th.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.